Copyright
©The Author(s) 2015.
World J Respirol. Nov 28, 2015; 5(3): 180-187
Published online Nov 28, 2015. doi: 10.5320/wjr.v5.i3.180
Published online Nov 28, 2015. doi: 10.5320/wjr.v5.i3.180
Group | Factor | Ref. | Design | Level of factor in PMA | Level of factor in non PMA | P vaule | Evidence level1 |
Hormones | Estrogen | Pasaoglu et al[41] | Pre-post study | PM: 89.3 pg/mL | PM: 72 pg/mL | N/A | 4 |
Estrogen | Pereira et al[40] | Cross-sectional study | PO: 111.49 pg/mL PM: 95.9 pg/mL | PO: 131.31 pg/mL PM: 123.83 | (for change) 0.845 | 4 | |
Progesterone | Pasaoglu et al[41] | Pre-post study | PM: 7.3 pg/mL | PM: 9.2 pg/mL | N/A | 4 | |
Progesterone | Pereira et al[40] | Cross-sectional study | PO: 0.83 pg/mL | PO: 1.39 pg/mL | (for change) 0.225 | 4 | |
PM: 6.82 pg/mL | PM: 6.31 | ||||||
Estrogen/ | Pereira et al[40] | Cross-sectional study | PO: 219.26 pg/mL | PO: 356.6 | 0.865 | 4 | |
Progesterone | PM: 35.53 pg/mL | PM: 355.22 | 0.371 | ||||
LH | Pasaoglu et al[41] | Pre-post study | PM: 3.5 mU/mL | PM: 4.9 mU/mL | N/A | 4 | |
FSH | Pasaoglu et al[41] | Pre-post study | PM: 13.3 mIU/mL | PM: 3.3 mIU/mL | N/A | 4 | |
Inflammation | LTC4 | Nakasato et al[19] | Pre-post study | PO: 24.0 pg/mL | PO: NA1 | NA | 4 |
PM: 69.0 pg/mL | PM: NA1 | ||||||
LTC4 | Pereira et al[52] | Cross-sectional study | PO: 1.5 ng/mL | PO: 1.4 ng/mL | NS | 4 | |
PM: 1.31 pg/mL | PM: 1.29 | ||||||
Prostaglandin F2α | Eliasson et al[53] | Cross-sectional study | Early cycle: 143 pg/0.1 mL | 169.3 pg/0.1 mL | NS1 | 4 | |
Late cycle: 15.9 pg/0.1 mL | 9.5 pg/0.1 mL | NS1 | |||||
Atopy | Total IgE (geometric mean) | Pereira et al[47] | Cross-sectional study | 206.31 | 87.99 | 0.01 | 4 |
Total IgE (% > 100 kU/L) | Pereira et al[47] | Cross-sectional study | 84 | 43 | 0.001 | 4 | |
Total IgE (mean) | Rao et al[48] | Cross-sectional study | 208.4 | 292.2 | 0.06 | 4 | |
Phadiatop (% +) | Pereira et al[47] | Cross-sectional study | 68 | 50 | 0.17 | 4 | |
Skin prick test + | Rao et al[48] | Cross-sectional study | 60 (76%) | 297 (88%) | 0.01 | 4 | |
Others | Aspirin sensitivity | Rao[48] | Cross-sectional study | 23 (39%) | 36 (10%) | < 0.0001 | 4 |
Use of aspirin or non-steroidal anti-inflammatory drugs | Forbes[58] | Cross-sectional study | 14/38 (36.8%) | 172/421 (40.9%) | NS | 4 |
- Citation: Pereira-Vega A, Sánchez-Ramos JL. Questions relating to premenstrual asthma. World J Respirol 2015; 5(3): 180-187
- URL: https://www.wjgnet.com/2218-6255/full/v5/i3/180.htm
- DOI: https://dx.doi.org/10.5320/wjr.v5.i3.180